Evidence map›Paper›PMID 26530382›Full record

ArticlemBio2015

Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis.

Kaifan Dai, Linling He, Salar N Khan, Sijy O'Dell, Krisha McKee, Karen Tran, Yuxing Li, Christopher Sundling, Charles D Morris, John R Mascola and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A VScience advances · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Analyzing Immunoglobulin Repertoires.Frontiers in immunology · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Germline-targeting immunogens.Immunological reviews · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Kaifan DaiDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Linling HeDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Salar N KhanDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Sijy O'DellVaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA.
Krisha McKeeVaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA.
Karen TranIAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.
Yuxing LiInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.
Christopher SundlingDepartment of Microbiology and Tumor Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Charles D MorrisDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
John R MascolaVaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA.
Gunilla B Karlsson HedestamDepartment of Microbiology and Tumor Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Richard T WyattDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA wyatt@scripps.edu jiang@scripps.edu.
Jiang ZhuDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA wyatt@scripps.edu jiang@scripps.edu.
Scripps Research Institute · USNational Institutes of Health · USKarolinska Institutet · SEAdvanced Bioscience Laboratories (United States) · USInternational AIDS Vaccine Initiative · US

Funding

Support Component D/Vaccine Discovery, Concept to ClinicUM1AI100663 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI AHMED, RAFI · 2012 to 2018
$131.5M
Non-Human PrimatesP01AI104722 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI KARLSSON HEDESTAM, GUNILLA · 2014 to 2018
$14.6M
High-resolution definition of B cell responses to HIV Env for immunogen designR01AI102766 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI LI, YUXING · 2013 to 2024
$6.6M
NIAID NIH HHS P01 AI104722NIAID NIH HHS R01 AI102766NIAID NIH HHS R01AI102766NIAID NIH HHS UM1 AI100663NIAID NIH HHS UM1AI 100663
6 · The paper itself

Abstract

unlabelledNext-generation sequencing (NGS) has been used to investigate the diversity and maturation of broadly neutralizing antibodies (bNAbs) in HIV-1-infected individuals. However, the application of NGS to the preclinical assessment of human vaccines, particularly the monitoring of vaccine-induced B-cell responses in a nonhuman primate (NHP) model, has not been reported. Here, we present a longitudinal NGS analysis of memory B-cell responses to an HIV-1 trimer vaccine in a macaque that has been extensively studied by single B-cell sorting and antibody characterization. We first established an NHP antibodyomics pipeline using the available 454 pyrosequencing data from this macaque and developed a protocol to sequence the NHP antibody repertoire in an unbiased manner. Using these methods, we then analyzed memory B-cell repertoires at four time points of NHP immunization and traced the lineages of seven CD4-binding site (CD4bs)-directed monoclonal antibodies previously isolated from this macaque. Longitudinal analysis revealed distinct patterns of B-cell lineage development in response to an HIV-1 trimer vaccine. While the temporal B-cell repertoire profiles and lineage patterns provide a baseline for comparison with forthcoming HIV-1 trimer vaccines, the newly developed NHP antibody NGS technologies and antibodyomics tools will facilitate future evaluation of human vaccine candidates. IMPORTANCE: The nonhuman primate model has been widely used in the preclinical assessment of human vaccines. Next-generation sequencing of B-cell repertoires provides a quantitative tool to analyze B-cell responses to a vaccine. In this study, the longitudinal B-cell repertoire analysis of a rhesus macaque immunized with an HIV-1 trimer vaccine revealed complex B-cell lineage patterns and showed the potential to facilitate the evaluation of future HIV-1 vaccines. The repertoire sequencing technologies and antibodyomics methods reported here can be extended to vaccine development for other human pathogens utilizing the nonhuman primate model.

Indexed as

Cell LineageImmunologic MemoryAIDS VaccinesAnimalsAntibodies, MonoclonalAntibodies, NeutralizingBinding Sites, AntibodyB-LymphocytesComputational BiologyDatabases, GeneticHigh-Throughput Nucleotide SequencingHIV-1HIV AntibodiesHIV InfectionsHumansMacaca mulattaAIDS VaccinesAntibodies, MonoclonalAntibodies, NeutralizingHIV Antibodies

Identifiers

PMID26530382
PMCPMC4631801
OpenAlexW2134728990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.